Investing

Merck, Cardinal Health Drop into Monday's 52-Week Low Club

November 20, 2017: Here are four stocks trading with heavy volume among 64 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by about 3 to 2 and on the Nasdaq, advancers led decliners by about the same spread.

Merck & Co. Inc. (NYSE: MRK) dropped about 2.9% Monday to post a new 52-week low of $53.63 after closing at $55.02 on Friday. The 52-week high is $66.80. Volume was around 12.7 million, more than 25% above the daily average of about 10 million. The company’s chief competitor in a combo therapy for lung cancer reported a successful phase 3 trial.

Omega Healthcare Investors Inc. (NYSE: OHI) dropped about 2.6% Monday to post a new 52-week low of $26.43 after closing at $27.14 on Friday. The 52-week high is $35.14. Volume was around 5.3 million, more than double the daily average of around 2.3 million. The healthcare REIT had now specific news.

Curis Inc. (NASDAQ: CRIS) matched a 52-week low of $0.88 set Friday. The 52-week high is $3.48. Volume was about 4 million, four times the daily average of around 1 million. The drugmaker had no specific news Monday.

Cardinal Health Inc. (NYSE: CAH) dropped about 4.9% Monday to post a new 52-week low of $54.67 after closing at $57.51 on Friday. The stock’s 52-week high is $84.88. Volume of around 4 million was about 40% above the daily average. The drug distributor was named by Morgan Stanley as the most susceptible to an Amazon attack on the pharmaceuticals business.

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.